The TyG–ALT index, calculated as ln(fasting TG [mg/dL] × fasting glucose [mg/dL] × ALT [U/L]/2), presented in this study is different from the formula presented in previous studies, and this is the first time that it has been related to the severity of NAFLD. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.